Dec 12, 2013: How to Ace the SBIR Application!

You are invited to attend:

InnoVentures U –

The ABCs of Non-Dilutive Funding…
Or, Successfully Tapping the SBIR Well

Thursday, December 12, 2013, 8:00 AM – 10:00 AM

Where: 100 Cummings Center (Beverly) — Conference Room 221 E

The Small Business Innovation Research programs of the US government (SBIR/STTR) provide billions of dollars of research support to translate innovative ideas into useful products. However, the programs are highly competitive and applications to various governmental agencies (e.g., NIH, NSF, DoD) differ greatly, with success rates generally below 20% and falling as the sluggish economy yields fewer tax dollars dedicated to support such research.

We’ve heard from you and we’re responding to your needs.This panel-driven program is designed to address your questions and concerns on how you can improve your chances of creating a compelling, top-notch application to greatly increase your chances of winning that coveted grant.

Be sure to attend…

If you’re the CEO of a biotech company who has applied for or is considering applying for an NIH SBIR grant;

If you’ve missed the Dec. 5 application deadline, this program will give you a jump start on the April deadline;

Anyone who has or is planning to apply for an SBIR grant (NSIV Members, Mentors, Advisors, Affiliates — all are welcome!)

In this session, we will share new information and improvements to our NSIV SBIR application “pre-review” process,as well as tips and suggestions based on feedback from SBIR Applicants and NSIV Reviewers collected over the past year. Topics include:A Survey of Funding Opportunities (NIH, DoD, NSF)
Logistics on e-Registration & Eligibility Requirements
Tips for — and Examples of — Competitive Proposals
Deciphering “Summary Statements”
Strategies for Reapplication

Program Format: There will be a 40-minute presentation by Dr. Kranz, followed by a 20- minute Q&A

Dr. Janice Kranz,Consultant, JK Consulting, has served as a reviewer on many SBIR study sections for the NIH and has written successful Phase I and Phase II SBIRs. Since 1993 she has worked at Cubist Pharmaceuticals, Proteome, ALS-TDI and, most recently the Broad Institute. Dr. Kranz has written or co-written successful proposals to the DoD, NIH, and several private foundations totaling over $170 million, on topics from anti-infectives, biological informatics, ALS, cancer, and psychiatric disease genetics and drug discovery. For the last year she has focused her work on helping other companies (startup and established) navigate the nebulous paths of securing non-dilutive funding.Moderator:Dr. Donald Kirsch, CSO, Cambria BiosciencesPanelists: Dr. Ellen Guthrie, Senior Scientist, New England Biolabs; Dr. Joan Brooks, COO, Garbrook, Inc.Grants Program Team: Joan Brooks; Don Kirsch; Marty Farmer; Sue Long